The Direct Cost and Incidence of Systemic Fungal Infections
Top Cited Papers
- 1 January 2002
- journal article
- research article
- Published by Elsevier in Value in Health
- Vol. 5 (1) , 26-34
- https://doi.org/10.1046/j.1524-4733.2002.51108.x
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Epidemiology of nosocomial fungal infections: invasive aspergillosis and the environmentDiagnostic Microbiology and Infectious Disease, 1999
- Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)Clinical Infectious Diseases, 1999
- The Epidemiological Features of Invasive Mycotic Infections in the San Francisco Bay Area, 1992-1993: Results of Population-Based Laboratory Active SurveillanceClinical Infectious Diseases, 1998
- The Impact of Candidemia on Length of Hospital Stay, Outcome, and Overall Cost of IllnessClinical Infectious Diseases, 1998
- Economic Analysis of Fluconazole versus Amphotericin B for the Treatment of Candidemia in Non-Neutropenic PatientsPharmacoEconomics, 1998
- Cost Analysis of Candida Infection among Surgical Intensive Care Unit PatientsClinical Drug Investigation, 1996
- Epidemiology of Nosocomial Fungal Infections, with Emphasis on Candida SpeciesClinical Infectious Diseases, 1995
- Epidemiology and Control of Fungal InfectionsClinical Infectious Diseases, 1994
- Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990The Journal of Infectious Diseases, 1993
- Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989The American Journal of Medicine, 1991